Table 4 Evaluation of the sensitivity of... | American Society of Hematology

Table 4

Evaluation of the sensitivity of biomarker combinations in the diagnosis of chronic GVHD

Number of positive plasma biomarkers(sBAFF, sIL-2Ra, anti-dsDNA, sCD13)*	Early		Late†		TotalcGVHD
	cGVHD	Control	cGVHD	Control	TotalcGVHD
0	5	19	2	12	7
1	9	7	4	2	13
2	6	0	2	0	8
3	10	0	3	0	13
4	4	0	0	0	4

Number of positive plasma biomarkers(sBAFF, sIL-2Ra, anti-dsDNA, sCD13)*	Early		Late†		TotalcGVHD
	cGVHD	Control	cGVHD	Control	TotalcGVHD
0	5	19	2	12	7
1	9	7	4	2	13
2	6	0	2	0	8
3	10	0	3	0	13
4	4	0	0	0	4

Positive values for early cGVHD as established by the ROC analysis (Table 3).

†

All positive values for late cGVHD values were identical to early except for sBAFF, established by an estimate (>2.0 ng/mL = positive, late) due to the fact numbers were not sufficient to perform ROC analysis.

View Large

This Feature Is Available To Subscribers Only